4//SEC Filing
Fehr Gordon J. 4
Accession 0001179110-13-006873
CIK 0001274792other
Filed
Apr 15, 8:00 PM ET
Accepted
Apr 16, 6:02 PM ET
Size
8.5 KB
Accession
0001179110-13-006873
Insider Transaction Report
Form 4
Fehr Gordon J.
Director
Transactions
- Exercise/Conversion
Common Stock
2013-04-15$2.19/sh+15,000$32,850→ 205,143 total - Sale
Common Stock
2013-04-15$6.04/sh−15,000$90,645→ 190,143 total - Exercise/Conversion
Stock Option (right to buy)
2013-04-15−15,000→ 0 totalExercise: $2.19Exp: 2013-05-08→ Common Stock (15,000 underlying)
Footnotes (3)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.98 to $6.14, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- [F3]This option is fully vested.
Documents
Issuer
MERRIMACK PHARMACEUTICALS INC
CIK 0001274792
Entity typeother
Related Parties
1- filerCIK 0001531946
Filing Metadata
- Form type
- 4
- Filed
- Apr 15, 8:00 PM ET
- Accepted
- Apr 16, 6:02 PM ET
- Size
- 8.5 KB